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I ntestinal transplantation is no longer an experimental procedure and is thc treatment of choice for patients with irreversible intestinal failure that cannot be maintained on total parenteral nutrition 
(TPN). The intestine was a forbidden organ to be transplanted in humans until the 1980s due to its rich 
lymphoid contcnt that precipitates either host-versus-graft or graft-versus-host alloreactivity. 
These immunologic barriers were 
initially recognized and appreciated in 
the dog models studied by Lillehei 1 and 
Starzl.2 The evolution of intestinal 
transplantation has distantly paralleled 
that for kidney and li\'er transplanta-
tion. Despite the anilability of 
cyclosporin A (CyA) since the begin-
ning of the last decade, the delay in the 
clinical success of intestinal transplanta-
tion was mainlv due to refractory allo-
graft rejectio'n, host infectio'n and 
~omplcxity of the operation. Although 
the intestine was one of the first organs 
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to be transplanted experimentally, it 
has been the last to be successfullv 
transplanted in humans. Before the c1in'-
ical introduction of eyA, intestinal 
transplantation was successfully per-
formed in seven patients and despite 
the use of azathioprine, steroid, anti-
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lymphocyte globulin, or thoracic duct 
drainage, all died of rcjcction and/or 
sepsis within thc first 10 wecks after 
transplantation. l With the clinical intro-
duction and provcn thcrapcutic benefits 
of CyA, the Toronto group performed 
thc first intestinal transplantation using 
CyA in 1986, but the patient dicd dur-
ing thc early post-opcrative period. 
Before the clinical introduction of 
tacrolimus (FKS06) sevcral othcr 
patients had bccn transplantcd under 
CyA based immunosuppl·ession and all 
of thcm except one succumbed to 
rejection and/ or scpsis. Thc only sur-
vivor is a Frcnch girl who rcceivcd an 
isolated small bowel transplant morc 
than 11 years ago. 4 She was recently 
switchcd from Cy A to tacrolimus based 
immunosupprcssion and has bccn off 
TPN for many years with full nutrition-
al autonomy. 
Clinical introduction of tacrolimus 
during the sccond half of 1989 trig-
gcred a new interest in intestinal trans-
plantation. Based upon the Intcr-
national Transplant Registry5 databasc 
more than 33 centcrs worldwide are 
currently pel·forming intcstinal trans-
plantation. Up to February of 1997, 
mOlT than 280 intestinal transplants 
were pcrformcd in Europc and in 
North America. 
CAUSES OF INTESTINAL FAILURE 
Maintcnancc of normal gastrointesti-
nal function includes the coordination 
of a series of complex intcractions. 
Despite thc essential regulatory role of 
the central nervous system, impairmcnt 
of the digestive, absorptive, neuroen-
docrine, and motor functions of the 
gastrointestinal system are the primary 
causes of gastroenteric failure. Intestinal 
insutllciency can be defincd as the loss 
of the absorptive capacity of the nativc 
intestinal mucosal, with the inability to 
maintain adequate nutrition and proper 
homcostasis of body fluids and e1cc-
trolytes. The most common cause of 
intestinal failure is the development of 
short gut syndrome due to either the 
anatomical loss of the intestine or its 
congcnital abscncc. Under these cir-
cumstanccs, thc rcmaining intcstine 
undergoes a serics of adaptiye changes 
which consist of incrcase in thc diamc-
ter of thc rcmaining bowel,and the 
length of the yilli. This adaptation phe-
nomenon is probably stimulated by the 
intraluminal nutricnts, pancrcatico-
biliary secretions, gut hormones and 
other enterotropic factors. The adapta-
tion process includes three phases: 
phase I (7 to 10 days), when diarrhca is 
severe and patients require massive fluid 
and electrolyte replacement; phase II (1 
to 3 months), when diarrhea stabilizes 
and patients still need TPN and other 
mcdical treatment; and phasc III (3 to 
12 months), when diarrhea is con-
trolled enough to allow enteral feeding 
and weaning from TPN. 7 If TPN cannot 
be discontinued 12 to 24 months after 
the initial insult, intestinal failure 
approachcs an irreversible state, neces-
sitating pcrmanent TPN therapy. 
At the timc of the surgical resection 
of thc small bowel, it is very difficult to 
predict the risk of intestinal failurc. 
However, the length of the remaining 
small bowel, the location of the resec-
tion, the presence of thc colon, and the 
presen'ation of the ileocecal valve are 
important factors that dctermine 
revcrsibility of the gut failure. ~.q In gen-
eral, rcsection of more than 70% of the 
total length of the small bowel with loss 
of the right colon, including the ileoce-
cal valve, is associated with a high inci-
dencc of ineversible intcstinal failurc. 
INDICATION FOR TRANSPLANTATION 
Irreversible (chronic) intcstinal fail-
ure and the permanent nccd for TPN is 
currently an absolute rcquirement for 
intestinal transplantation. Inevel·sibility 
is based upon length/pathophysiologic 
status of the remaining native bowel and 
failurc of medical managcment during 
thc thrce phascs of adaptation. Thc cur-
rent indications for intestinal transplan-
tation are primarily short gut 
syndrome, gastrointestinal dysmotility 
(pscudo-obstruction), prcmalignant 
gastrointestinal tumors, and impaired 
enterocytc absorptive capacity. Thc 
individual causes of these syndromes 
are the follOWing: 
1. short gut syndromc: nccrotizing 
entcrocolitis, intestinal atrcsia, 
midgut voh·ulus, complicated gas-
troschisis, abdominal trauma, 
Crohn's disease, surgical adhe-
sions. Gardener's syndrome, 
dcsmoid tumor, and/or mcscn-
teric vascular thrombosis. 
2. Defective intcstinal motility: hol-
low yisceral myopathy. neuropa-
thy, and/or total intcstinal 
aganglionosis. 
3. Impaired cnterocyte absorptive 
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capacity: micI·ovillus inclusion 
diseasc, selectivc autoimmune 
enteropathy, radiation cnteriti 
extensive inflammatory bow 
disease and / or massive intestin"j 
polyposis. 
Combined liver and small bowel 
transplantation is considered the onl~' 
thcrapeutic option availablc for patients 
with irrcversible failure of both th(' 
liver and thc intestine. Livcr failure ill 
these unique patients is usual 
cholestatic and is primarily relatcd 
thc prolonged usc of TPN. In SOIl!(' 
patients, genetic and metabolic errors 
of the hepatocytes, including hyperco-
agulability with thrombosis of thc por-
tomesenteric and visceral arterial 
system, are the leading causes of 
abdominal organ failure. The manifesta· 
tions of liver failure in these patient~ 
includc ascites. refractory varicl' , 
bleeding, spontaneous bacterial pe 
tonitis, chronic hcpatic encephalopath:" 
hepatorenal syndrome, and failure to 
thrivc. 
Multivisceral transplantation is usu-
ally offered for patients with irre-
yersible failure of three or more of thl' 
abdominal visceral organs, including thl' 
small bowel and for those with exten-
sive low-grade malignant tumors of : I 
gastrointestinal tract. The individ 
causes arc extcnsive thrombosis of the 
splanchnic venous system, massivc gas-
trointestinal polyposis, and generalized 
hollow visceral myophathy or neuro-
pathy. 
PRE-TRANSPLANT WORK-UP 
Patients who are candidates r 
intestinal transplantation usually reql 
a clinical guided work-up. A thorougH 
c\'aluation, which includes a completl' 
history and physical cxamination with 
full assessment of the nutrition,ll. 
hepatic, renal, cardiopulmonary, hema-
tologic, and immunologic status. is 
nceded for each potential recipient. 
Other specific tests should bc indi-
vidualized based upon the nature, SCY"· 
ity, and extent of thc primary dise~ 
In a patient with short gut syndrome, it 
is necessary to assess the residual func-
tion of the remaining nativc small 
bowel, particularly those with diffuse 
intestinal diseases. This can bc achieved 
by full radiologic, cndoscopic, and 
pathologic examinations of thc rcmain-
ing intestine. 
---------- ---_._._-------------------
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FlglJre 1. The segmental blood supply of the different parts of the gastrointesti-
nal tract is shown. (From Fung JJ, Abu·E1magd K. Todo S. Intestinal and multi· 
visceral transplantation. Digestive tract surgerY a text and atlas 1996, 
1229-1261 Lippincott·Raven, used with permission). 
Figure 2. Donor operation with an abdominal transverse cruciate incision. 
(From Fung JJ, Abu·E1magd K, Todo S. Intestinal and multivisceral transplanta· 
tion. Digestive tract surgery a text and atlas 1996, 1229-1261 Lippincott • 
Raven, used with persmission). 
Motility studies of the upper and 
lower gastrOintestinal tract are 
also mandatory for patients with pseu-
do-obstruction syndromes. Further-
more, cases of thrombotic disorders 
require abdominal visceral angiography 
and special hematologic studies includ-
ing measUI-ement of protcin C, pl"Otcins 
S, and antithrombin III in the serum, 
and detection of factor II and V muta-
tions. 
In patients with desmoicl tumors, 
new imaging techniques such as MRI 
should also be used to delineate the 
extent of the tumor, including its rela-
tion to the adjacent Yital stl-uctures. 
Finally, particular attention should be 
paid to assess the extent of I i\'Cr damage 
and status of hepatic reserve. If the liver 
injury tests are elevated, a liYel- biopsy 
should be performed to assess the need 
for liver replacement. 
DONOR SELECTION 
The criteria used to select potential 
small bowel donors are the same as 
those used for the isolated liver allo-
grafts. Hemodynamically stable and 
young age donors are usually preferred. 
All donOl-s should be ABO identical to 
the recipient, and of smaller size and 
weight. 
The histocompatibility locus antigens 
(HLA) match of the donor and recipient 
is not required with no attempts to 
deplete the donor lymphoid mass. 
Transplanting the intestine across a 
strong positive Iymphocytotoxic cross-
match should be avoided when possible, 
particularly with isolated intestinal 
grafts. 
Cytomegalovirus (CMV) positive 
grafts are currently not lIsed for CMV 
seronegative isolated intestinal recipi-
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ents. IO Selective gut decontamination 
should be attempted in all donors. 
Amphotericine-B, tobramycinl gen-
tamicin, and polymyxin-E arc given 
through a nasogastric tube once the 
donor has been accepted and then every 
6 hours until the time of procUl"ement. 
University of Wisconsin (UW) solution 
is used for the in situ flush and for the 
preserYation of the graft. The abdomi-
nal visceral organs are usually harvested 
en bloc and fashioned on the back table 
based on the intraoperative Hndings and 
recipient needs. 
TECHNICAL ASPECTS OF THE DONOR 
OPERATION 
A kev factor in the success of intesti-
nal tran'splantation is the procurement 
of good quality graft. In order to per-
form the proper donor operation for 
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Figure 3. Composite liver and intestinal graft with preservation of the duodenum in continuity with the 
graft jejunum and hepatic biliary system. Note transaction of the pancreas to the right of the portal vein 
with preservation of the pancreaticoduodenal arterial and venous arcade. The technique reduces the time 
of the recipient operations and avoids the potential risk of biliary reconstruction. 
Figure 4. The split graft prepared for implantation. Vascular homografts have been attached with an aortic 
conduit to the left side, and separate arterial and venous grafts to the right side. IVC, inferior vena cava: 
RPV, right portal vein; RHA, right hepatic artery; RDH right hepatic duct; CBD common bile duct; PV portal 
vein; HA hepatic artery; CA, celiac artery; SMA, superior mesenteric artery; SMV superior mesenteric vein. 
(From Reyes J, Fishbein T, Bueno J, et al. Reduced-size orthotopic composite liver-intestinal allograft. 
Transplantation 1998, 66: 489-492, used with permiSSion). 
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the three difTerent grafts, it is impor-
tant to know the embryonic origin of 
the blO'od supply of the different p 
O'f the alimentary tract as shO'wn in 
ure 1. 
Isolated Intestine 
The retrieval prO'cedure starts VI'ith a 
cruciate abdominal incisiO'n (Figure 2). 
The greater omentum is carefully di,-
sected and separated frO'm the trans-
verse mesO'cO'lon. After an extensiYl" 
Kocher maneuver is completed 
cecum, ascending cDlon, and m< 
terium arc mobilized from lilt 
retroperitoneum. The right and middk 
CO'lic vessels are diYided and the ileum b 
transected at the ileocecal \·alve. Th, 
proximal jejunum is divided close to th(· 
ligament of Trictz. The third and l<lUrth 
PO'rtion 0'1' the duO'denum arc further 
mobilized and dissected from the root 
of the mesenterium by dividing' Ii 
numerous branches fr;)m the s~p 
mesenteric vessels. By transecting ,d(" 
pylO'rus and neck of the pancreas, thl' 
portal and the superior mesenteric ve' 
sels arc exposed dissected h'om the pan 
creas and duodenum by interrupting 
small pancreatic and duodenal archades. 
Isolated harvesting of bO'tb the intestilw 
and pancreas arc technically feasible ,111<1 
were successfully pcrformed in 
than 8 dO'nors in our series. The 
abdominal aorta is cannulated after ,;\"~, 
temic heparinization of the donO'r ;\1.1 
perfused with UW solution. To scI"\ 
rate the liver from the intestine, till' 
pm-tal vein is transected above the eOIl-
fluence of the superior mesenteric ,lilt! 
splenic vein. A Carrel patch is I." 
chioned at the origin of the celiac trllld, 
and the superior mesenteric arten 
intestine is then removed and imn, 
in the UW solution. A vascular CO'I1\,uli 
is then usually anastomO'sed, when indi 
cated, to the superior mesenteric v(" 
sels during the back table procedure. 
Liver / in tcstinc 
The liver is initially mobilized from 
its suspensory ligaments and the entin' 
cO'IO'n is mobilized from its retn 
toneal attachment with division' ,l' 
gastrocO'lic omentum. The vessels \, ;Lh-
in the mesentery of the terminal i1eulll, 
right, transverse and left colon alT 
divided and the entire colon is rotated 
to the left and removed out of the field 
after dividing the distal ileum, as pn·Yi · 
allsl" described with the standard mul-
tipl~ organ harvest. II After complct:ng 
Tranlplantation 
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Figure 5. Different type of intestine and composite intestinal grafts. (From Furukawa H, Abu·Elmagd K, 
Reyes J, et al. Technical aspect of intestinal transplantation Surgical Technology International II, Universal 
Medical Press, Inc. pp. 165·170, 1994 used by pennission). . 
Figure 6. Vascular anastomosis of the isolated intestinal transplantation. Four type of venous anastomosis 
of the donor superior mesenteric vein (SMV) to (AI the main trunk of the portal vein, (B) the confluence of 
the superior mesenteric vein and the splenic vein, Ie) the distal end of the superior mesenteric vein, ID) 
the inferior vena cava of tile recepient. (From Furukawa H, Abu·Elmagd K, Reyes J, et al. Technical aspecl 
of intestinal transplantation Surgical Technology Interniitionalll, 1994, Po 165·1701. 
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an extensive Kocher maneuver the right 
gastric and gastroe piploic vessels are 
. divided and the pylorus is transected, 
which allows the stomach to be reflect-
ed cephalad. The distal pancreas and the 
spleen are then mobilized and reflected 
medially. The dissection of the tail and 
body of the pancreas is then continued 
until the confluence of the splenic and 
superior mesenteric vein is identified . 
The pancreas is then transected at the 
lev.e l of the neck leaving the head and 
uncinate process in continuity with the 
duodenum and carefully preserving the 
superior and inferior pancreati coduode-
nal arcades (Figure 3). This step could 
be done in siw or on the back table. 
This tec hnique Significantly decreased 
the rate of biliary complications and 
shortened the operative time . 
In a pediatri c case, the left lateral 
hepatiC segment and small howel were 
successfully transplanted after an in situ 
split was performed at our institution 
to overcome a donor/recipient size 
mismatch in a 3-year-old child who was 
dying because of combined Ii ver-small 
bowel failure (Figure 4) . 
Multivisceral Graft 
The harvest of a multi visce ral graft, 
which includes the stomach, duode-
num, pancreas, intestine, and liver is 
similar to the technique used for the 
liver/intestine retrieval. ll . l • The key 
portion of the operation is the proper 
orientation of the organs and their \'us-
cular pedicles. The gastrohepatic liga-
ments and its contents are left intact, 
but the gallbladder is opened and 
flushed. The gastroesophageal junction 
is transected using thc gastrointestinal 
stapler. Splenectomy is carried out 
either during the harvesting procedure 
or on the back tahle by ligating the 
spleniC vessels close to the splenic hilus 
in order to amid injury of the tail of the 
pancreas. After completion of the UW 
aortic flush, the multivisceral graft is 
removed en bloc . Placement of the arte -
rial conduit and performance of the 
pyloroplasty are done on the back table. 
RECIPIENT OPERATION 
The technique used for removing the 
remaining native organs and implanting 
the intestinal graft either alone or in 
eo·.lbination with other abdominal 
organs varies according to the nature of 
the primary disease and extent of pre\'i-
"US abdominal surgery. Figure 5 shows 
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Figure 7. Types of arterial grafts used as vascular conduits for combined hepatic - intestinal and multivis-
ceral grafts. The first arterial anastomosis shown is the one most often used. CA celiac artery; IMA inferior 
mesenteric artery; SMA superior mesenteric artery. (From Furukawa H, Abu-Elmagd K, Reyes J, et a!. 
Technical aspect of intestinal transplantation Surgical Technology International II, Universal Medical 
Press, Inc., 1994, p. 165-1701. 
Figure 8. Isolated and composite intestinal transplantation. 
the three different types of intestinal 
allografts. The ahdominal cavity is usu-
ally entered through an extended cruci-
ate incision, especially in cases with 
multiple previous alxlominal surgery 
and portal hypertenSion with marked 
vascular adhesion s. In general, the 
ahdominal dissection is easier 'A·hen the 
,~mall bowel alone has to he transpbnt-
ed because of the ahsence of sianificant 
liver disease and portal hyper~e nsion. 
The upper abdomen exenteration per-
formed dUl·ing multivisceral transplan -
tation is thc most difficult part of thE' 
three proccdures, particularly in the 
presence of liver failure and extensive 
vascular thrombosis. Contracture or the 
ahdominal cavity and defective ahdomi-
nal wall in patients with prel'ious multi-
ple abdominal surgeries comhined with 
post-reperfusion edema of the trans-
planted bowel prese nts another techni-
cal challenge at the time of closure of 
the ahdominal wall incision. In the 
majority of cases, small sized donors 
and innovatil'e techniques are required 
to accommodate the allograft and 
reconstruct the recipient abdominal 
\\'all. Temporary use of synthetic mate-
rials and utilization of split thickn ess 
skin grafts 0]" myocutaneo us naps arc 
usually needed for .~ome recipients. 
Isolate Intestine 
The superior mesenteric artery of 
the isolated intestinal graft is anasto-
mosed in an end to side fashion to the 
reCipient infrarenal aorta. In difficult 
cases, an interposition graft is anasto-
mosed 11rst to the recipient aorta, Con-
trovers), still exists rE'garding the venous 
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drainage of th e isolated intestine (Fig-
ure 6). Based upon our current results, 
systemic venous drainage does not si 
nificantly affect the risk of rejection 
graft sUfl'ival. 1\ Therefore, the currc"r 
recommendation is to utilize the sys-
temic drainage for cases with diFficult 
hilar dissection, previous transplanta-
tion, and prolonged cold ischemia time. 
The proximal end of the intestinal 
graft can be anastomosed to the recipi-
ent duodenum, or residual native 
jejunum, A jejunostomy tube is all", , , 
inserted for early graft decompres> 
and enteral feeding. In patients \\, 1" , 
previous proctocolcctomy, the distal 
end of the intestinal graft is exterior-
i:Gcd as an end ileostomy. An il eocolic or 
ilcoilcal anastomosis is per formed in 
patients with residual native colon or 
il e um. A temporary vent chimney is 
always performed for patients in whom 
continuity or the distal gastrointesti Ti , I 
tract is achieved. The ileostomy all, 
easy access for endoscopies and c<> 
stant surveillanee of the graft. Surgical 
closure of the vent il eostomy is recom-
mended 3 to 6 months after transplan-
tation. For grafts that contain part of 
the donor colon, a Bishop-Coop 
ileostomy is usually reguired. 
Liver lintestine 
With combined liv er /intest i 
transplantation, recipients are subject " , 
to the well known hemodynamic an(1 
m e taboli c changes that commonly 
occur during the an hepatic phase, and 
aFter reperfusion, In these patients, the 
use of the I'e no -venous bypass is usually 
compromised hy the coexistence of sig-
nificant stenosis or thrombosis of the 
superior vena cava due to the long-tn 
use of central venous catheten. The: 
fore, thc pl-ocedure of choice for t l" 
hepatectomy is th e piggy-hack 
tecnigue. If, 
With the com bined liver-small 
bowel transplantation, venous drainage 
of the natil'C left splanchniC venous sys-
tem to the recipient cava (portocaval 
shunt) is required before dissection of 
the native gut in onler to minimize tf·, 
operative blood loss. The conversion 
portoportal shunt after reperfusion ,), 
the allograft is not recommendcd in 
cases with small donor pOI-tal vein in 
order to amid the potential risk of por-
tal vein thrombosis. The arterial inflow 
is es tablished by an end-to-side anasto-
mosis between the arterial graft and the 
reCipient infrarenal aorta. The arterial 
T ransplan ration 
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Figure 9. Graft survival according to the time of transplantation at the University of Pittsburgh Medical 
Center. (From Abu-Elmagd K, Reyes J, Fung JJ, et al. Evolution of clinical intestinal transplantation: 
Improved outcame and cost effectiveness. Transplant Proc lin press) used with permission). 
graft (Figure 7) is mounted during the 
back table proccdure and is anasto-
mosed to the Canel patch, which 
includcs the origin of both the donor 
celiac tI-unk and superior mesenteric 
artery. The graft is Hushed with blood 
and the intcstinal continuity is later 
established as described with ;he isolat-
ed intcstinal transplantation. 
Multivisceral 
The multivisceral transplantation is 
an en bloc procedure as shown in Figure 
8 (right inscrt). [n this procedurc, the 
proximal alimentary tract anastomosis 
is established between the recipient 
esophagus and the donor stomach. 
Also, the biliarv system is tcmporarilv 
decompressed a~d 'the bile flow is exte;-
nally divertcd through a cystic duct 
catheter to prevent postoperative pan-
creatitis and to facilitate early diagnosis 
of ampullary dysfunction (Figure 8). 
Post-Operative Management 
The difficultics in the postoperative 
managemcnt of small bowel transplant 
recipients are primarily due to multiple 
immunologic and biologic barriers; the 
massi\'e lymphoid content of thc gut, 
thc heavv bacterial load of the intestinal 
lumen a~d thc complexity of the graft 
absorptive and neuroenteric functions. 
Full details of the postoperative man-
agement of the intestinal allograft recip-
icnts are described elsewhcre. li 
Immunosuppression 
The immunosupplTssive therapy uti-
lizcd at our center is based primarily on 
tacl"Olimus and prednisone; cyclophos-
phamide is added as an induction thera-
py for some patients at a dose of 2 to 3 
mg/kg/day for 4 weeks, and then 
switched to mycophenolate mofetil (15 
to 30 mg/kg/day) or azathioprine. In a 
few cases, azathioprine was givcn as a 
third drug from the outset. In thc most 
recent cases, thc ncw humanized [L-
2R-specific monoclonal antibody 
(daclizumab; Zenapax) is added as an 
induction therapy. 
Thc level of maintenance immuno-
suppression is individualizcd and adjust-
ed based upon the clinical course of 
each paticnt with the intention to 
reduce thc drug dosage and levels 
whcnevcr possible. Rejection episodes 
are treated with stcroid bolus/taper and 
optimization of tacrolimus therapy. 
OKT3 is uscd onlv as a rescue therapv. 
Upward close adj~stl11ent of mycoph~­
nolate, mofetil, azathioprine, 01-
steroids, are frequently necdcd to com-
pensate for tacrolimus dosc reductions 
mandated bv tacrolimus-related adverse 
effects. -
PATIENT SURVIVAL 
Our Experience 
In our institution in Pittsburgh, PA, 
for the pcriod bl,tween May 2 1990 and 
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July 17 1998, a total of 115 intcstinal 
transplant were performed in 109 con-
secutive patients. The overall patient 
survival is 72% at 1 year and 48% at 5 
ycars with a graft survi val ratc of 64 
and 40% respectively. With a mean fol-
low-up of 40±29 months (range of 1 to 
94), 31 patients arc alive with good 
nutrition beyond the third postopcra-
tive vear, and 18 are well bevond the 5 
yca/milestone. The survival'bcnefits of 
intestinal transplantation has hccn bet-
ter (p ::: 0.57) achicvcd among children 
comparcd to adults vvith best outcome 
among patients between 2 and 17 years 
of age with a 5 year cumulativc survival 
rate of 68%. Although thc survival rate 
of the isolated intcstine and the com-
posite grafts was similar (p = 0.72), the 
cumulative risk of graft loss due to 
rcjection was significantly highcr (p = 
0.045) among the isolated small bowel. 
Figure 9 depicts the significant 
improvemcnt (p = 0.04) in intestinal 
allograft sun-ivai at our center during 
the last 4 vcars with a cumulative ratc 
of 65% at 4. years. These results are duc 
to improvement in surgical techniques 
and postoperative managemcnt of this 
unique population. 
Worldwide Experience 
A total of 273 intestinal transplant 
were performed in 260 consccutivc 
patients in 33 centers worldwidc. Of 
these transplants, 41 % were isolated 
intestine, 48% were combined intes-
tinc/liver, and 11 % were multivisceral. 
The patient survival at 1 and 5 years 
was 80% and 55% for thc isolated 
intestine, 65% and 40% for the com-
bined li\"l~r/intcstine, and 4-5% and 
35% for the multi visceral transplants, 
respectively. The graft survival rate at 1 
and 5 ycars was 50 and 30% (isolatcd 
intestine), 60 and 32% (col11bint'd 
liver/intestine) and 40 and 35% (multi-
visceral) respcctively. i 
COMPLICATIONS 
Transplant Rejection 
The diagnosis of intestinal rcjcction 
is currently achievable utilizing a high 
index or clinical suspicion, frequent 
suneillancc endoscopic biopsies, and 
well established histopathologic crite-
ria. 17 The current incidence of rcjection 
ranges from 73 to 93% and most of the 
episodes arc mild to moderate. About 
50% of the episodes occur within the 
first 3 months after transplantation with 
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a higher incidence among the isolated 
intestine compared to the intestine con-
tained in a composite graft and a similar 
cumulative rejection rate within the first 
year after transplantation (Figure 10A). 
HowewT, the rate of intestinal graft loss 
from rejection is significantly lower among 
the composite grafts (Figure 11 ).IX In the 
recipients of composite grafts, the inci-
dence of liver rejection is less than half 
of that in the intestine (Figure 10B).IR 
Infections 
Bacterial, fungal and viral infections 
pose a very high risk of mortality in the 
transplant recipients because of the use 
of immunosuppressants. With intestinal 
transplantation, such a risk is signifi-
cantly increased because of the possible 
disruption of the mucosal barrier with a 
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subsequent increase in bacterial translo-
cation. With intestinal rejection, the 
treatment of the above-described clini-
cal picture paradoxically consists of , 
rational increase in the dosage of the 
immunosuppressive drugs. 
Intestinal allograft recipients are at 
high risk of developing systemic and 
intra·abdominal sepsis. Central line 
infection and bacterial/fungal transloca-
tion, are the two most frequent sources 
of svstemic infections. Patients with 
inc~mplete abdominal closure anei 
those who receive a portion of th 
colon with the intestinal graft arc mon 
prone to develop intra-abdominal infcc-
tions.lo.1920 Furthermore, surgical 
manipulation of the transplanted bowel, 
lymphatic disruption, graft dysmotility, 
absence of ileocccal valve, suppression 
of gastric acidity, high steroid dosc, 
postopcrativc need for temporary intra-
venous nutrition and enteral-definc(: 
formula diet have all been implicated i 
the development of bacterial over· 
growth among the intcstinal recipi-
ents. 20 
The incidence of cytomega-
loviral (eM V) infection, ranges from 
23% to 36%.I.IS,21 It has already been 
reported that the incidence of infection 
is higher for the CMV positive-to-nega-
tive and positive-to-positive donO" 
recipient combination. The adu 
population are at a higher risk of de\"t~I­
oping the CMV disease with a similar 
rate among the three different types of 
grafts. The ayoidance of using positive-
to-negative combination and the devel-
opment of ncw strategies to prevent 
heavy chronic immunosuppression 
without the penalty of rejection has sig-
nificantly decreased thc incidence ( 
CMV infection.lI 
POSTTRANSPLANT LYMPHOPROLIFERATIVE 
DISEASE [PTLDl 
The overall incidence of PTLD 
ranges from 10% to 20% with a higher 
risk in children of 27%.1.1R The inci-
dence varies with thc three diffcrcnt 
types of intestinal allograft; 11 % for th 
isolate intestine, 21 % for tI 
liver/intcstine and 33% for the multi-
visceral. The three major risk factors 
for the development of PTLD are 
young age, multivisceral transplanta-
tion, and recipient splenectomy. 
Lymphatic Leak 
A significant problem that may occur 
early after intestinal transplantation is 
the development of a lymphatic leak, 
which is due to interruption of the 
lymph vessels at the time of surgery.22 
The initiation of enteral feeding usually 
produces variable degree of chylous 
ascites or external leak and determines 
large amounts of fluid loss. In most 
patients, the process is usually self-lim-
ited and easily controlled with lovv or 
fat free diet and use of medium-chain 
triglyceride enteral formula. In a very 
few cases, fluid and electrolyte replace-
ment arc required for a variable period 
of time with partial intravenous nutri-
tion. 
Graft-Versus-Host Disease 
Despite the large lymphoid mass 
contained in the intestine, only 1 1 % of 
the small bowel patients in our series 
developed graft-vel'sus-host disease 
(GYHD), which was histologically con-
firmed in only 5%.2l The diagnosis is 
usually based upon the recognition of 
suspicious skin lesions and development 
of gastrointestinal symptoms. The skin 
lesions should be promptly biopsicd and 
studied using conventional histopatho-
logiC methods, immunohistopathologic 
staining for donor-specific HLA anti-
gen, and in situ hybridization technique 
using the Y chromosome-specific 
probe. This morbidity is usually sclf-
limited and responds to augmentation 
of immunosuppression. 
COST ANALYSIS 
An analysiS was performed to com-
pare the cost of an isolated intestinal 
transplantation to the yearly cost of 
TPN. With combined liver and intesti-
nal failure the cost analysis is not justi-
fied since hepato-intestinal trans-
plantation is the only life-saving treat-
ment for these patients. The cost of the 
three types of transplants has been sig-
nificantly reduced at our institution 
during the last 4 years. The average cost 
of the operation, between 1990 and 
1994, was $203,111 for the isolated 
small bowel, $252,453 for the com-
bined livel--small bowel and $284,452 
for the composite multivisceral graft. 
Over the last 4 years a significant reduc-
tion in the total loading cost have been 
achieved with an average value of 
$132,285, $214,716 and $219,098 
Transplantation 
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respectively. Based upon the 1992 
Medicare data, the yearly cost of TPN 
was above S 150,000, not including the 
cost of frequent hospitalization, medical 
and nursing care. 2+ Therefore, small 
bowel transplantation becomes cost-
effective by the second year after trans-
plantation. 
CONCLUSION 
Intestinal transplantation has become 
a life-saving treatment for patients with 
irreversible intestinal failure who can-
not be maintained on TPN, and a cost-
effective therapy for patients who still 
have the option of TPN. 
The long-term rehabilitation follow-
ing intestinal transplantation alone or in 
combination with other intra-abdomi-
nal organs is similar to that achieved 
with lung transplantation. 21 It is there-
fore justifiable to consider intestinal 
transplantation as a non-experimental 
procedure. In addition, further 
immunomodulation of the intestinal 
allograft by cytoreduction could further 
improve survival outcome and possibly 
raise intestinal transplantation to be the 
standard of care for all patients with 
chronic intestinal failure. EiID 
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